Responsible research & innovation (RRI) Project directory

COMPASS has compiled an overview of RRI projects and initiatives carried out in Europe over the course of the past ten years. The COMPASS project directory below contains 130 publicly funded RRI projects in Europe. Our project directory aims to facilitate the search for RRI projects in Europe. You can download search instructions here.

For a quick look at the key figures check out our factsheet. For a detailed outline, have a look at the COMPASS policy paper, which maps out approaches, objectives and thematic priorities of publicly funded RRI projects at European level, and describes their spread across Europe via budget shares and numbers of participations.

You can find more information, results and project output on responsible innovation in the European Commission’s database CORDIS, as well as the RRI Toolkit!

Over the course of the project, it has become evident that rules, regulations and funding criteria could function as external incentives to implement responsible innovation in SMEs. The Vienna University of Economics and Business (WU), as coordinator of the COMPASS project, has therefore developed recommendations for EU research and innovation policy, with support of the COMPASS High Level Expert Advisory Board.


Project Acronym: QuantOCancer
Project Title: Leveraging the unique organismic approach to health and disease of the Champalimaud Foundation through the inception of a quantitative biomedicine research programme focused on cancer
Funding Programme: Horizon 2020
Responsible Innovation Dimension:
Description: The QuantOCancer project aims to attract and maintain an outstanding researcher and research manager to incept the quantitative biomedicine research programme focused on cancer at the Champalimaud Foundation (CF) that will allow consolidating and expanding CF’s internationally-leading position as a biomedical research excellence centre with a unique organismic approach to health and disease that smoothly integrates theoretical and experimental conceptual frameworks. The ERA Chair will: i) bring the needed critical mass to the recently created Biology of Systems and Metastasis research programme through the inception of a truly multidisciplinary and intersectoral research field; ii) effectively cement the CF Research Programme, by leveraging the installed research capacity in quantitative biomedicine; iii) root an effective bridge between research excellence and clinical practice at CF, through the creation of an innovative MD/PhD programme. The attractiveness of the CF as well as of the Lisbon region and the country will be fully unlocked through the implementation of an additional set of measures including: 1)institutional changes, aiming, among others, to further explore the installed R&T capacity; 2) capacity building activities, including the expansion of the advanced training opportunities to the postdoctoral community; and 3) intersectoral and international networking activities, open to external stakeholders, with a strong focus on the interface between EU and overseas opportunities. These will allow incepting and spreading a RRI culture in line with the ERA priorities as well as to endeavour EU and overseas collaborative efforts towards a truly open and international R&I global ecosystem. Trough QuantOCancer CF will boost its capacity to retain internationally competitive research funding in this way effectively contributing to the achievement of the regional and national smart specialisation goals and as such to reduce the EU disparities in R&I performance.

Responsible Innovation COMPASS

Evidence and Opportunities for Responsible Innovation in SMEs

Find out more